Description: S2Medical AB (publ) develops, produces, and sells wound healing products for burns and chronic wounds in Sweden, Norway, and Denmark. It offers Epiprotect 2117, a synthetic allograft/xenograft substitute; Epiprotect Ulcer, a wound dressing consisting of a thin film of biosynthetic cellulose polymer intended to be used as a protective barrier for superficial wounds and deep wounds that have breached the dermis, as well as used as a temporary coverage for deep extensive wounds before transplantation or other surgical intervention. The company also provides washable, durable, waterproof, and self-adhesive bandages under the INSTABIND brand name, as well as NO SMELL, a perfume-free odour remover. The company also distributes Silverlon dressings that deliver a flow of silver ions into the wound. In addition, it operates the wound healing center under the S2Clinic name. The company was incorporated in 2013 and is headquartered in Linköping, Sweden.
Home Page: www.s2m.se
Sunnorpsgatan 5
Linköping,
582 73
Sweden
Phone:
46 87 00 00 50
Officers
| Name | Title |
|---|---|
| Mr. Petter Sivlér | Co-Founder & CEO |
| Mr. Mårten Skog | Co-Founder, COO & Director |
| Ms. Ingvild Thiry Pizarro | Chief Financial Officer |
| Dr. Johan Thorfinn | Chief Clinical Officer |
Exchange: ST
Country: SE
Currency: Swedish krone (kr)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 3.417 |
| Price-to-Sales TTM: | 3.6422 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 17 |